User profiles for Christopher M Reid
 | Christopher ReidJohn Curtin Distinguished Professor, Curtin & Monash Universities Verified email at monash.edu Cited by 31619 |
[HTML][HTML] A comparison of outcomes with angiotensin-converting–enzyme inhibitors and diuretics for hypertension in the elderly
Background Treatment of hypertension with diuretics, beta-blockers, or both leads to improved
outcomes. It has been postulated that agents that inhibit the renin–angiotensin system …
outcomes. It has been postulated that agents that inhibit the renin–angiotensin system …
[HTML][HTML] Effect of aspirin on cardiovascular events and bleeding in the healthy elderly
Background Aspirin is a well-established therapy for the secondary prevention of cardiovascular
events. However, its role in the primary prevention of cardiovascular disease is unclear, …
events. However, its role in the primary prevention of cardiovascular disease is unclear, …
[HTML][HTML] Cholesterol lowering in intermediate-risk persons without cardiovascular disease
Background Previous trials have shown that the use of statins to lower cholesterol reduces
the risk of cardiovascular events among persons without cardiovascular disease. Those trials …
the risk of cardiovascular events among persons without cardiovascular disease. Those trials …
Pet ownership and risk factors for cardiovascular disease
WP Anderson, CM Reid… - Medical journal of …, 1992 - Wiley Online Library
Objective: To compare risk factors for cardiovascular disease in pet owners and non‐owners.
Design and patients: Accepted risk factors for cardiovascular disease were measured in …
Design and patients: Accepted risk factors for cardiovascular disease were measured in …
[HTML][HTML] Effect of aspirin on all-cause mortality in the healthy elderly
Background In the primary analysis of the Aspirin in Reducing Events in the Elderly (ASPREE)
trial, now published in the Journal, we report that the daily use of aspirin did not provide a …
trial, now published in the Journal, we report that the daily use of aspirin did not provide a …
[HTML][HTML] Blood-pressure lowering in intermediate-risk persons without cardiovascular disease
Background Antihypertensive therapy reduces the risk of cardiovascular events among high-risk
persons and among those with a systolic blood pressure of 160 mm Hg or higher, but its …
persons and among those with a systolic blood pressure of 160 mm Hg or higher, but its …
2-Hour accelerated diagnostic protocol to assess patients with chest pain symptoms using contemporary troponins as the only biomarker: the ADAPT trial
Objectives : The purpose of this study was to determine whether a new accelerated diagnostic
protocol (ADP) for possible cardiac chest pain could identify low-risk patients suitable for …
protocol (ADP) for possible cardiac chest pain could identify low-risk patients suitable for …
Effect of catheter ablation using pulmonary vein isolation with vs without posterior left atrial wall isolation on atrial arrhythmia recurrence in patients with persistent …
Importance Pulmonary vein isolation (PVI) alone is less effective in patients with persistent
atrial fibrillation (AF) compared with paroxysmal AF. The left atrial posterior wall may …
atrial fibrillation (AF) compared with paroxysmal AF. The left atrial posterior wall may …
[HTML][HTML] Effect of aspirin on disability-free survival in the healthy elderly
Background Information on the use of aspirin to increase healthy independent life span in
older persons is limited. Whether 5 years of daily low-dose aspirin therapy would extend …
older persons is limited. Whether 5 years of daily low-dose aspirin therapy would extend …
[HTML][HTML] Blood-pressure and cholesterol lowering in persons without cardiovascular disease
Background Elevated blood pressure and elevated low-density lipoprotein (LDL) cholesterol
increase the risk of cardiovascular disease. Lowering both should reduce the risk of …
increase the risk of cardiovascular disease. Lowering both should reduce the risk of …